BridgeMD
Tests treatment safety and results for Obsessive-Compulsive Disorder
Official title Efficacy and Influencing Factors of Deep Transcranial Magnetic Stimulation in the Treatment of OCD
ClinicalTrials.gov ID: NCT06692114
What this study is testing
- What it's testing
- This study aims to explore the efficacy and influencing of accelerated dTMS (deep Transcranial Magnetic Stimulation) treatment in patients with obsessive-compulsive disorder (OCD), and explores the potential neural mechanisms of treatment effect by magnetic resonance imaging (MRI) and electroencephalography (EEG).
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 50. Healthy volunteers may be eligible.
You may be able to join if
- Aged between 18 and 50, both genders are welcome.
- DSM-5 criteria for OCD.
- Y-BOCS total score ≥ 20 despite therapeutic-dose SRI treatment or completion of at least one full course of CBT. The treatment regimen must have been...
- More than 9 years of education.
- Right-handed.
You likely can't join if
- Any additional current psychiatric comorbidity, except for obsessive- compulsive personality disorder.
- Severe obsessive symptoms prevent the completion of necessary assessments.
- Has a history of receiving ECT therapy.
- Has received rTMS or tDCS treatment within the past two months.
- Has severe physical illnesses or any physical conditions that can induce epilepsy or intracranial hypertension, including cardiovascular and...
- Has a past history of neurological disorders (such as epilepsy, cerebrovascular accidents, etc.) or brain injuries, or a history of brain surgery.
See the full eligibility criteria
- Aged between 18 and 50, both genders are welcome.
- DSM-5 criteria for OCD.
- Y-BOCS total score ≥ 20 despite therapeutic-dose SRI treatment or completion of at least one full course of CBT. The treatment regimen must have been stable for at least 8 weeks prior to enrollment and remain unchanged...
- More than 9 years of education.
- Right-handed.
- Any additional current psychiatric comorbidity, except for obsessive- compulsive personality disorder.
- Severe obsessive symptoms prevent the completion of necessary assessments.
- Has a history of receiving ECT therapy.
- Has received rTMS or tDCS treatment within the past two months.
- Has severe physical illnesses or any physical conditions that can induce epilepsy or intracranial hypertension, including cardiovascular and respiratory diseases, among others.
- Has a past history of neurological disorders (such as epilepsy, cerebrovascular accidents, etc.) or brain injuries, or a history of brain surgery.
- Has implanted medical devices such as intracranial stents, cardiac pacemakers, coronary stents, cochlear implants, etc.
- Serious suicide risk.
- Pregnancy or nursing of an infant.
The study team makes the final eligibility decision.
Where it's taking place
- Shanghai, Shanghai Municipality, China
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 50 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Shanghai, Shanghai Municipality, China. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.